Response Genetics, Inc (RGDX) Stock Research, Analysis & News

Quick Analysis on Response Genetics, Inc (RGDX) Stock as of November 26, 2015

Previous Closing Price $0.03 is below its 50 day moving average $0.17
Previous Closing Price $0.03 is below its 200 day moving average $0.34
The Stock pays no dividend
The closing price $0.03 is more than 5,900.00% away from its one year target price of $1.800
Earning per Share $-0.367 is negative. Response Genetics, Inc is lossing money.
(See more information about Response Genetics, Inc (RGDX) Stock below)

Response Genetics, Inc (RGDX) Stock Profile Summary

Response Genetics, Inc., a life sciences company, engages in the research, development, marketing, and sale of clinical diagnostics and pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and Japan. It offers ResponseDX: Lung test suites for non-small cell lung cancer; ResponseDX: Colon test suites for colorectal cancer; and ResponseDX: Gastric test suites for gastric and gastroesophageal cancer. The companys Response DX test measures the RNA expression of ERCC1, TS, and RRM1 through reverse transcription polymerase chain reaction analysis from a patient's tumor tissue; and polymerase chain reaction analysis of DNA from the patient's sample to determine EGFR amplification, as well as BRAF, EGFR, and KRAS mutational status. It is also developing tests for other types of cancer that identify genetic profiles of tumors that recur after surgery. The company offers its products through its sales force to community based oncologists, hospitals, and physician offices. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Response Genetics, Inc (RGDX) Stock Key Statistics Research and Analysis as of November 26, 2015

Stock ExchangeNCM
Trade Volume (Average Trading Volume)0 (286,022)
Current Year EPS Estimate$-0.190
Next Year EPS Estimate$-0.150
Previous Closing Price$0.03
50 Day Price Moving Average$0.17
200 Day Price Moving Average$0.34
1 yr Target Price$1.800
PEG Ratio0.000
Short Ratio0.000

Response Genetics, Inc (RGDX) Stock Competitor Research and Analysis

Clinical Data, Inc. (CLDA)Genomic Health Inc. (GHDX)
Quest Diagnostics Inc. (DGX)

Latest Market News on Response Genetics, Inc (RGDX)

Click here to find the latest news on Response Genetics, Inc (RGDX)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Clinical Data, Inc. (CLDA)
Genomic Health Inc. (GHDX)
Quest Diagnostics Inc. (DGX)